Strateos Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Employees
  • 87
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $56.1M
Latest Deal Amount
  • Investors
  • 16

Strateos General Information

Description

Developer of a robotic cloud lab platform designed to accelerate drug discovery and synthetic biology research. The company's platform automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs, enabling pharmaceutical partners to rapidly and efficiently discover new drug candidates.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Enterprise Systems (Healthcare)
Biotechnology
Primary Office
  • 3565 Haven Avenue
  • Suite 3
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Strateos Timeline

20202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Strateos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 08-Jun-2021 $56.1M 000.00 00000 Completed Generating Revenue
3. Early Stage VC (Series A) 03-Jun-2019 000.00 000.00 000.00 Completed Startup
2. Seed Round $13M $13M 0000 Completed Startup
1. Merger of Equals 03-Jun-2019 Completed Startup
To view Strateos’s complete valuation and funding history, request access »

Strateos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.0 00.0 00.0 00 00.0 00.000
Series A3 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series A2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed 2 7,260,466 $0.000100 $0.09 $1.18 $1.18 1x $1.18 13.31%
Seed 1 4,190,792 $0.000100 $0.09 $1.11 $1.11 1x $1.11 7.68%
To view Strateos’s complete cap table history, request access »

Strateos Executive Team (2)

Name Title Board Seat Contact Info
Mark Fischer-Colbrie President & Chief Executive Officer
Christopher Krueger Chief Financial Officer
To view Strateos’s complete executive team members history, request access »

Strateos Board Members (4)

Name Representing Role Since
Armen Vidian DCVC Board Member 000 0000
Jeffrey Finer Ph.D Self Chairman 000 0000
Joshua Wolfe Lux Capital Management Board Member 000 0000
Mara Aspinall Self Vice Chairman 000 0000
To view Strateos’s complete board members history, request access »

Strateos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Strateos Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ally Bridge Group PE/Buyout Minority 000 0000 000000 0
Alumni Ventures Group Venture Capital Minority 000 0000 000000 0
Black Diamond Ventures Venture Capital Minority 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
Harmonix Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Strateos Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 03-Jun-2019 000000000000000000 Laboratory Services (Healthcare)
3Scan 26-Apr-2019 Merger/Acquisition Diagnostic Equipment
To view Strateos’s complete acquisitions history, request access »